Skip to content
Trial Eligibility
Menu

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention

NCT06785376

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HIV Testing
  • PrEP Uptake

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 65 years
Sex
Male
Healthy volunteers
Accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
August 31, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.